Assignee
UNIV HEIDELBERG RUPRECHT KARLS
DE·23 granted patents·20 pending applications·14 citations·filing 2012–2023
Top patents by PatentIndex Score
43 records- 0184US10967044B2Lipopeptides for use in treating liver diseases and cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2019·Granted Apr 6, 2021·2 cites·5 claims
- 0280US12370237B2Lipopeptides for use in treating liver diseases and cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2023·Granted Jul 29, 2025·0 cites·12 claims
- 0376US11401304B2Cyclic NTCP-targeting peptides and their uses as entry inhibitorsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Granted Aug 2, 2022·1 cites·8 claims
- 0476US10058591B2Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Granted Aug 28, 2018·3 cites·2 claims
- 0574US10253099B2Conjugates of proteins and multivalent cell-penetrating peptides and their usesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Apr 9, 2019·3 cites·20 claims
- 0674US9114101B2P16INK4A derived peptides for prophylaxis and therapy of HPV-associated tumors and other P16INK4A expressing tumorsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2012·Granted Aug 25, 2015·1 cites·4 claims
- 0772US10413585B2Lipopeptides for use in treating liver diseases and cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Sep 17, 2019·2 cites·19 claims
- 0866US10316367B2Circulating miRNAs as markers for breast cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Jun 11, 2019·1 cites·4 claims
- 0966US9914912B2ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2014·Granted Mar 13, 2018·1 cites·3 claims
- 1066US2022195398A1Abhd5 and partial hdac4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2022·Application pending·0 cites
- 1163US10682402B2MSI-specific frameshift peptides (FSP) for prevention and treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Granted Jun 16, 2020·0 cites·13 claims
- 1260US11312943B2ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2018·Granted Apr 26, 2022·0 cites·7 claims
- 1358US2023069933A1Measles virus encoding a tumor antigenUNIV HEIDELBERG RUPRECHT KARLS·Filed 2022·Application pending·0 cites
- 1456US11369669B2Measles virus encoding a tumor antigenUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Granted Jun 28, 2022·0 cites·9 claims
- 1556US2021000816A1Use of ccr5 antagonists alone or in combination therapy for the treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2020·Application pending·0 cites
- 1654US10792329B2S100 based treatment of cardiac power failureUNIV HEIDELBERG RUPRECHT KARLS·Filed 2014·Granted Oct 6, 2020·0 cites·8 claims
- 1753US11274132B2Combined preparations of PKM2 modulators and HMGB1UNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Granted Mar 15, 2022·0 cites·4 claims
- 1853US10618947B2Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animalsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Apr 14, 2020·0 cites·4 claims
- 1951US11072641B2HMGB1 tyrosine mutantsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Granted Jul 27, 2021·0 cites·14 claims
- 2050US2022118121A1Prostate specific membrane antigen (psma) ligands with improved tissue specificityUNIV HEIDELBERG RUPRECHT KARLS·Filed 2020·Application pending·0 cites
- 2150US2020157631A1CIRCULATING miRNAs AS MARKERS FOR BREAST CANCERUNIV HEIDELBERG RUPRECHT KARLS·Filed 2019·Application pending·0 cites
- 2247US2019194756A1Gene panel specific for pulmonary hypertension and its usesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Application pending·0 cites
- 2346US9938580B2Epigenetic signatures as marker for cardiomyopathies and myocardial insufficienciesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Apr 10, 2018·0 cites·12 claims
- 2445US2021155660A1Rationally designed virus-like particles for modulation of chimeric antigen receptor (car)-t-cell therapyUNIV HEIDELBERG RUPRECHT KARLS·Filed 2018·Application pending·0 cites
- 2544US2020051778A1Microtome, scanning electron microscope and method for preparing thin slices from a sample and method for analysing thin slices produced from a sample in a scanning electron microscope and use of a magnetic tape for the purpose of depositing and transporting of thin slices of samples in the field of scanning electron microscopyUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Application pending·0 cites
- 2643US2019119678A1Means and methods for inactivating therapeutic dna in a cellUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Application pending·0 cites
- 2742US2020131227A1Polypeptide with tumour binding activityUNIV HEIDELBERG RUPRECHT KARLS·Filed 2018·Application pending·0 cites
- 2841US10548960B2Malaria vaccines based on pre-erythrocytic antigens from P. falciparumUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Granted Feb 4, 2020·0 cites·8 claims
- 2941US2019275035A1Wnt antagonists and their use in methods for treating myocardial infarctionUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Application pending·0 cites
- 3039US11202833B2Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levelsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Granted Dec 21, 2021·0 cites·9 claims
- 3139US10941451B2Biomarker panel for the detection of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Granted Mar 9, 2021·0 cites·19 claims
- 3239US2016206699A1Use of interleukin 10 mrna transfected macrophages in anti-inflammatory therapiesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
- 3339US2019351069A1Coating of Nanoparticle Surfaces with Cyclopeptides for Improving Delivery of Agents Via the Oral RouteUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Application pending·0 cites
- 3437US2018169123A1Combination therapy with a flavagline and 2-deoxyglucoseUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
- 3536US2020370039A1Adeno-associated virus libraryUNIV HEIDELBERG RUPRECHT KARLS·Filed 2018·Application pending·0 cites
- 3635US2018155403A1Histone anti-cancer vaccinesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
- 3734US2018289689A1Use of ccr5 antagonists alone or in combination therapy for the treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Application pending·0 cites
- 3832US10254273B2Method and kit for assessment of sodium channel-related anti- or pro-arrhythmic potential of compoundsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Granted Apr 9, 2019·0 cites·16 claims
- 3932US2016052954A1Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cellsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Application pending·0 cites
- 4032US2018215787A1Chromogenic And Fluorogenic Peptide Substrates For The Detection Of Serine Protease ActivityUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
- 4131US2016075752A1B-type plexin antagonists and uses thereofUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Application pending·0 cites
- 4229US10119135B2Therapeutic micro RNA targets in chronic pulmonary diseasesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2013·Granted Nov 6, 2018·0 cites·15 claims
- 4324US10988795B2Synthesis of double-stranded nucleic acidsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Granted Apr 27, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when UNIV HEIDELBERG RUPRECHT KARLS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →